Caribou Biosciences, Inc. (CRBU)
0.4093
-0.01
(-2.50%)
USD |
NASDAQ |
Nov 10, 16:00
0.4093
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Cash from Operations (Annual) : -110.99M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -110.99M |
| December 31, 2024 | -138.20M |
| December 31, 2023 | -93.29M |
| December 31, 2022 | -90.97M |
| Date | Value |
|---|---|
| December 31, 2021 | -32.52M |
| December 31, 2020 | -33.22M |
| December 31, 2019 | -32.01M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anavex Life Sciences Corp. | -39.04M |
| Vaxcyte, Inc. | -655.58M |
| Foghorn Therapeutics, Inc. | -86.10M |
| Bolt Biotherapeutics, Inc. | -39.85M |
| Connect Biopharma Holdings Ltd. | -51.21M |